Cutaneous larva migrans. A report of eight cases;Larva migrans cutánea. Presentación de 8 casos

Actas Dermo-Sifiliograficas

Volumn 93, Issue 7, 2002, Pages 443-447

  Santandreu, Mireia Sàbat ^b   Pibernat, Miquel Ribera ^b   Narsol, Isabel Bielsa ^b   Cavalle, Jordi Rex ^b   Foraster, Carlos Ferrándiz ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b NONE

Author keywords

Albendazole; Creeping eruption; Cutaneous larva migrans; Larva migrans; Thiabendazole

Indexed keywords

ALBENDAZOLE; IVERMECTIN; MEBENDAZOLE; TIABENDAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN TISSUE; LARVA MIGRANS; MALE; PRURITUS; SIDE EFFECT; SKIN BIOPSY; SKIN DEFECT;

EID: 0345417635     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(02)76608-8     Document Type: Article

References (20)

1. Elliot DL, Tolle SW, Goldberg L, Miller JB. Pet-associated illnesses. N Engl J Med 1985;313:985-95.
2. Herbert D, Davies, Sakuls P, Keystibe JS. Creeping eruption. Arch Dermatol 1993;129:588-91.
3. Blackwell V, Vega-López F. Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveller. Br J Dermatol 2001;145:434-7.
4. Adell MT, Ribera M, Vaquero M, Ferrándiz C. Larva migrans cutánea. Estudio de tres casos. Piel 1991;6:370-3.
5. Jelinek T, Maiwald H, Nothdurft HD, Löscher T. Cutaneous larva migrans in travelers: synopsis of symptoms, and treatments of 98 patients. Clin Inf Diseases 1994;19:1062-6.
6. Caumes E. Treatment of cutaneous larva migrans. Clin Infect Dis 2000;30:811-4.
7. Guil M, Odom R. Larva migrans complicated by Löffler's syndrome. Arch Dermatol 1978;114:1525-6.
8. Loughrey MB, Irvine AD, Girdwood RWA, McMillan JC. Cutaneous larva migrans; the case for routine oral treatment. Br J Dermatol 1997;137:149-61.
9. Rubio S, Ruiz L, Gascón J, Corachán M. Larva migrans cutánea en viajeros. Med Clin (Barc) 1992;98:224-6.
10. Kurgansky D, Burnett JW. Creeping eruption. Cutis 1990;45:399-400.
11. Rueda M, Martín F, Cerro M, López E, Suárez R, Sánchez F. Larva cutánea migrans. Ann Esp Pediatr 1996;45:291-2.
12. Rodilla F, Colomina J, Magraner J. Current treatment recommendations for cutaneous larva migrans. Ann Pharmacother 1994;28:672-3.
13. Orihuela A, Torres J. Single dose of albendazole in the treatment of cutaneous larva migrans. Arch Dermatol 1990;126:398-9.
14. Verladi S, Rizzietelli G. Effectiveness of a new therapeutic with albendazole in cutaneous larva migrans. Eur J Dermatol 1999;9:352-3.
15. Jones SK. Cutaneous larva migrans-recurrens. Br J Dermatol 1994;130:546.
16. Rizzitelli G, Scarabelli G, Veraldi S. Albendazole: a new therapeutic regimen in cutaneous larva migrans. Int J Dermatol 1997;36:700-3.
17. Jones SK, Reynolds NJ, Oliwiecki S, Harman RRM. Oral albendazole for the treatment of cutaneous larva migrans. Br J Dermatol 1990;122:99-101.
18. Caumes E, Datry A, Paria L, Danins M, Gentilini M. Efficacy of iverrnectin in the therapy of cutaneous larva migrans. Arch Dermatol 1992;128:994-5.
19. Van den Endem E, Setevens A, Van Gompel A. Treatment of cutaneous larva migrans. N Engl J Med 1998;22:1246-7.
20. Caumes E, Carriere J, Datry A. A randomised trial of ivermectin versus albandazole for the treament of cutaneous larva migrans. Am J Trop Med Hyg 1993;49:641-4.